Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacteriostatic versus bactericidal activity.

M J Mulligan1, C G Cobbs

  • 1Department of Medicine, University of Alabama, Birmingham.

Infectious Disease Clinics of North America
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data.

mBio·2023
Same author

Optimized Quantification of Intrahost Viral Diversity in SARS-CoV-2 and Influenza Virus Sequence Data.

bioRxiv : the preprint server for biology·2023
Same author

The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and prevention.

Mucosal immunology·2016
Same author

Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults.

AIDS research and human retroviruses·2006
Same author

Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.

Journal of virology·2001
Same author

A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects.

Vaccine·2001
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Antimicrobial susceptibility testing helps doctors choose the right antibiotics to kill or inhibit bacteria. Further trials are needed to confirm if standardized susceptibility testing predicts treatment success for bacterial infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotics can inhibit bacterial growth or cause cell death.
  • Laboratory methods assess antimicrobial agent activity.
  • Physicians use these tests to guide antimicrobial therapy selection for infections.

Purpose of the Study:

  • To evaluate the role of laboratory methods in guiding antimicrobial therapy.
  • To determine if specific infections necessitate bactericidal (bacteria-killing) antibiotics.
  • To assess the need for further multicenter trials on standardized susceptibility testing (SBT).

Main Methods:

  • Review of laboratory methods for determining antimicrobial activity.
  • Analysis of clinical scenarios requiring specific antibiotic action (inhibitory vs. bactericidal).

Related Experiment Videos

  • Identification of the need for standardized susceptibility testing (SBT) trials.

    • Main Results:

    • Laboratory methods are available to determine the effectiveness of antimicrobial agents.
    • Some infections specifically require bactericidal antimicrobial therapy for resolution.
    • Current evidence suggests a need for more extensive trials.

    Conclusions:

    • Antimicrobial susceptibility testing is crucial for selecting appropriate antibiotic treatments.
    • Bactericidal therapy is essential for certain infectious diseases.
    • Standardized susceptibility testing requires further validation through multicenter trials to predict patient outcomes accurately.